InteliCare Trial Commencement at mecwacare
| Stock | Intelicare Holdings Ltd (ICR.ASX) |
|---|---|
| Release Time | 11 Jul 2025, 11:50 a.m. |
| Price Sensitive | Yes |
InteliCare Trial Commences at mecwacare
- Three-month trial of InteliCare at mecwacare's Trescowthick Centre in Prahran, Victoria has commenced
- mecwacare deploying InteliCare solution as part of its digital strategy and commitment to innovation
- New features released to support mecwacare's operating model and achieve desired outcomes
InteliCare Holdings Ltd (ASX: ICR), an Australian Software-as-a-Service (SaaS) technology company, has announced the commencement of a three-month trial of its InteliCare platform at mecwacare's Trescowthick Centre in Prahran, Victoria. The trial is part of mecwacare's assessment of InteliCare to inform its digital transformation and innovation journey across the organization. The implementation of InteliCare at The Trescowthick Centre has involved the release of a number of new features on the platform, including enhanced reporting for falls and other alarm events, real-time location services enhancements, real-time resident status dashboards, smartphone-based alarms delivery and response for care staff, and fridge temperature monitoring and reporting. These new features have been developed specifically to support mecwacare's operating model and help the organization achieve the outcomes it is seeking.At the end of the three-month trial period, mecwacare will make a decision about further deployments of InteliCare across its residential aged care facilities. This initial agreement includes $212k for hardware and implementation services.InteliCare CEO Daniel Pilbrow expressed excitement about the commencement of the trial, stating that the project teams from both groups have worked extremely well together over the past two months to get the trial underway. Kendall Killbride, mecwacare General Manager Information Technology Transformation, also shared the organization's excitement about working with InteliCare and looking forward to analyzing the data and results of the trial.